This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Shandong Xinchuang Biotechnology Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Laitian Xing: Innovator in Cancer Treatment
Introduction
Laitian Xing is a notable inventor based in Jinan, China. He has made significant contributions to the field of medicine, particularly in the treatment of non-small cell lung carcinoma. His innovative approach has led to the development of a unique patent that showcases his expertise and dedication to advancing cancer therapies.
Latest Patents
Laitian Xing holds a patent for the "Application of Derivatives of Clostridium Ghonii," specifically focusing on the application of derivatives of MW-DCG-HNCv-18 in the preparation of medicines for treating non-small cell lung carcinoma. This patent discloses a medicine that combines the derivatives of MW-DCG-HNCv-18 strain with Docetaxel as the active ingredients. The invention highlights that the MW-DCG-HNCv-18 strain exhibits a specific inhibition effect on non-small cell lung carcinoma for the first time. The inhibition effect is significantly superior to that of other known similar strains. Furthermore, through screening, it has been found that the MW-DCG-HNCv-18 strain has a more prominent inhibition effect on non-small cell lung carcinoma when combined with Docetaxel injection.
Career Highlights
Throughout his career, Laitian Xing has worked with various companies, including Shandong Xinchuang Biotechnology Co., Ltd. and Shandong Xinchuang Biological Technology Co., Ltd. His work in these organizations has allowed him to collaborate with other professionals in the field and contribute to groundbreaking research.
Collaborations
Laitian Xing has collaborated with notable coworkers such as Yong Wang and Mingqian Wei. These partnerships have played a crucial role in the development of his innovative ideas and patents.
Conclusion
Laitian Xing is a prominent inventor whose work in cancer treatment has the potential to make a significant impact on the medical field. His patent on the application of derivatives of Clostridium Ghonii demonstrates his commitment to advancing therapeutic options for patients with non-small cell lung carcinoma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile